t.vanhecke
Submits third-party assay reports on material purchased directly. Based in Izmir.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.23%
n=9
Suppliers covered
5
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041260 | Semaglutide | WWB | WWB-2604-J2590 | PeptideMeter | 2026-Q2 | 99.93 | 7.02 | 104.1 | Supplier-supplied | 0 | PASS |
| AX-2026-042054 | Tirzepatide | TFC | TFC-2508-L6746 | Janoshik | 2026-Q1 | 98.34 | 1.81 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042261 | GHRP-6 | Homopeptide | HOMO-2508-W1724 | Janoshik | 2025-Q4 | 99.93 | 5.82 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019404 | Tirzepatide | Homopeptide | HOMO-2510-E8656 | Janoshik | 2025-Q4 | 98.68 | 5.23 | 94.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019141 | PEG-MGF | TFC | TFC-2507-M4201 | Janoshik | 2025-Q3 | 98.02 | 3.75 | 95.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019136 | PEG-MGF | TFC | TFC-2507-M4201 | VendorInvestigate | 2025-Q3 | 96.87 | 4.30 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020788 | PT-141 (Bremelanotide) | SGN | SGN-2412-Y9700 | Janoshik | 2025-Q1 | 97.95 | 6.74 | 94.1 | Laboratory-retained | 2 | FAIL |
| AX-2024-005321 | Tirzepatide | SGN | SGN-2408-S9172 | Janoshik | 2024-Q4 | 98.03 | 3.35 | 105.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004999 | Semaglutide | GGPeps | GGPE-2404-D2105 | Janoshik | 2024-Q2 | 98.23 | 7.14 | 90.6 | Supplier-supplied | 1 | MARGINAL |
| Supplier | Records | Median purity |
|---|---|---|
| TFC | 3 | 98.02 |
| Homopeptide | 2 | n<3 |
| SGN | 2 | n<3 |
| WWB | 1 | n<3 |
| GGPeps | 1 | n<3 |